{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"ESSA Pharma Inc."},"Symbol":{"label":"Symbol","value":"EPIX"},"Address":{"label":"Address","value":"999 WEST BROADWAY STREET,SUITE 720, VANCOUVER, British Columbia, V5Z 1K5, Canada"},"Phone":{"label":"Phone","value":"+1 778 331-0962"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival."},"CompanyUrl":{"label":"Company Url","value":"https://www.essapharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alessandra Cesano","title":"Chief Medical Officer & Executive Vice President"},{"name":"David R. Parkinson","title":"President, Chief Executive Officer & Director"},{"name":"Peter A. Virsik","title":"Chief Operating Officer & Executive Vice President"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}